GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for 3-methyl-2-oxobutanoate hydroxymethyltransferase (Q21F95)

Analyse AlphaFold monomer V2.0 prediction for 3-methyl-2-oxobutanoate… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
Q21F95
Type
protein
Length
270 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xF8cD1d8d93E9783063700De244A6e3cf6A195579
Molecule
3-methyl-2-oxobutanoate hydroxymethyltransferase
UniProt
Q21F95
Pockets
3 · best druggability 0.70

Structure

1 distinct chain · 44% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3-methyl-2-oxobutanoate hydroxymethyltransferaseprotein27044% helix, 14% strandQ21F95

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12360.700.8533empty
21150.430.7722empty
3910.340.7421empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.